TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Option Overview for Gastrointestinal Neuroendocrine Tumors
Source: Gastrointestinal Neuroendocrine Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Treatment options for patients with gastrointestinal neuroendocrine (carcinoid) tumors include:
Surgery.
Somatostatin analogues.
Interferons.
Treatment of hepatic metastases.
Radionuclides.
Management of neuroendocrine tumor–related fibrosis.
Symptomatic therapy.
Molecular-targeted therapies (under clinical evaluation).
Therapies for symptomatic relief.
Antifibrotic therapies (under clinical evaluation).[1]
Source links and citations
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice